Neovasc Inc.

Recent News

  • Neovasc Announces Participation in Noble Capital Markets Virtual Road Show Series

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - December 1, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), today announced their participation in Noble Capital Markets' Virtual Road Show Series, presented by Channelchek, scheduled for December 8, 2020.The virtual road show will feature a corporate presentation from Neovasc President & CEO, Fred Colen, followed by a Q & A session proctored by Noble Biotechnology Research Analyst Ahu Demir, Ph.D., featuring questions submitted by the audience.The live...

    2020-12-01 4:30 PM ET
  • Neovasc to Participate in Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum

    Vancouver, British Columbia--(Newsfile Corp. - November 16, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN), today announced that company management will be participating in the Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020. Fred Colen, Neovasc's President and Chief Executive Officer, will deliver a presentation at 11:00 am EST. Mr. Colen will also be joined by Chief Financial Officer Chris Clark, and Chief Operating Officer Bill Little, for investor meetings throughout the day.A...

    2020-11-16 4:46 PM ET
  • Neovasc Announces Third Quarter Financial Results

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 5, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today reported financial results for the third quarter ended September 30, 2020.Third Quarter HighlightsGrew revenue 25% year-over-year in the quarter.Implants increased 50% year-over-year in the quarter including 100% growth in the important DACH countries: Germany,...

    2020-11-05 4:05 PM ET
  • Neovasc Announces FDA Advisory Panel Result on Neovasc Reducer(TM) Medical Device for the Treatment of Refractory Angina

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - October 28, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the United States Food and Drug Administration's (FDA's) Circulatory System Devices Advisory Panel voted 14 to 4 "in favor" that the Neovasc Reducer™ is safe when used as intended, and voted 1 to 17 "against" on the issue of a reasonable assurance of effectiveness. The third vote was 13 to 3 "against" (2 abstained) on whether...

    2020-10-28 6:00 AM ET
  • Neovasc to Report Third Quarter Financial Results on November 5, 2020

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - October 22, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) today announced that it will report financial results for the quarter ended September 30, 2020 after the market close on November 5, 2020. Neovasc President and Chief Executive Officer Fred Colen, and Chief Financial Officer Chris Clark will host a conference call to review the company's results at 4:30 PM Eastern Time.Interested parties may access the conference call by dialing...

    2020-10-22 8:00 AM ET
  • Neovasc to Sponsor Symposium on Treating Patients with Refractory Angina at TCT Connect 2020

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - October 13, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that it will sponsor a symposium entitled "Unmet Need in Treating Patients With Refractory Angina" at the 2020 TCT Connect Online Conference, taking place October 14-18, 2020.The training session will be available via the TCT Connect e-satellite for registered participants beginning Friday, October 16, at 7 AM EDT. The session will feature presentations by:Prof. Tommaso Gori,...

    2020-10-13 7:00 AM ET
  • Neovasc to Participate in H.C. Wainwright & Co. 22nd Annual Global Investment Conference

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - September 8, 2020) -  Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today announced that its management team will be participating in the 22nd Annual H.C. Wainwright Global Investment Conference on September 14-16, 2020. Fred Colen, Neovasc's President and CEO, will present on September 15 at 3:30 pm...

    2020-09-08 4:10 PM ET
  • Neovasc Inc. Reports Results of Annual General Meeting of Shareholders

    Vancouver, British Columbia--(Newsfile Corp. - September 3, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on September 3, 2020 in Vancouver, B.C. (the "Meeting").At the Meeting, the shareholders of the Company (the "Shareholders") re-elected board members Steven Rubin, Paul Geyer, Doug Janzen, Norman Radow, Alexei Marko and Fred Colen to serve in office until the...

    2020-09-03 3:41 PM ET